| |
| |
|
| Insider
Information: |
Wilkinson George Fred |
| Relationship: |
Chief Executive Office... |
| City: |
Woodcliff Lake |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
444,649 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,494,445 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
444,649 |
|
|
| Total
Value |
$5,494,445 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 61.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allergan plc |
AGN |
PRES-ACTAVIS SPECIALTY... |
2013-11-27 |
15,412 |
2013-10-01 |
0 |
Premium* |
|
|
Impax Laboratories Inc |
IPXL |
Chief Executive Office... |
2016-04-29 |
429,237 |
2014-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2016-04-29 |
4/A |
D |
$33.35 |
$3,242,254 |
D/D |
(97,219) |
429,237 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2016-04-29 |
4 |
D |
$33.35 |
$2,054,160 |
D/D |
(61,594) |
464,862 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
89,332 |
526,456 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2016-02-26 |
4 |
D |
$33.27 |
$185,214 |
D/D |
(5,567) |
437,124 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2015-10-29 |
4 |
D |
$35.75 |
$587,194 |
D/D |
(16,425) |
442,691 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2015-04-29 |
4 |
D |
$46.36 |
$5,322,267 |
D/D |
(114,803) |
459,116 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
68,000 |
573,919 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2014-10-29 |
4 |
D |
$28.19 |
$537,893 |
D/D |
(19,081) |
505,919 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Chief Executive Officer |
• • – |
2014-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
525,000 |
525,000 |
0 |
- |
|
| AGN |
Allergan plc |
PRES-ACTAVIS SPECIALTY BRANDS |
• – – |
2013-11-27 |
4 |
S |
$165.00 |
$3,995,805 |
D/D |
(24,217) |
15,412 |
0 |
- |
|
| AGN |
Allergan plc |
PRES-ACTAVIS SPECIALTY BRANDS |
• – – |
2013-11-25 |
4 |
S |
$165.00 |
$247,830 |
D/D |
(1,502) |
39,629 |
0 |
- |
|
| AGN |
Allergan plc |
PRES-ACTAVIS SPECIALTY BRANDS |
• – – |
2013-11-22 |
4 |
S |
$165.00 |
$706,365 |
D/D |
(4,281) |
41,131 |
0 |
- |
|
| AGN |
Allergan plc |
PRES-ACTAVIS SPECIALTY BRANDS |
• – – |
2013-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,412 |
45,412 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
